Clinical trial · Interventional
The Role of Biofeedback in Improving Continence After Anterior Resection
NCT00515853CI-TRIAL-00056925completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether biofeedback exercises improve anal continence after anterior resection for rectal cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Aged | — | UNRESOLVED | — |
| Fecal Incontinence | — | UNRESOLVED | — |
| Rectal Neoplasms | Rectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biofeedback | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Biofeedback
- description
- Received feedback
- interventionNames
- Behavioral: Biofeedback
- type
- NO_INTERVENTION
- label
- No biofeedback
- description
- Did not received feedback
Primary outcomes (1)
- measure
- Cleveland Clinic Incontinence (CCI) Score
- timeFrame
- 1 year
- description
- The Cleveland Clinic incontinence score (CCI) is an anal incontinence severity score. It is easy to use and gives the patient a score of 0 to 20, where zero equates to perfect continence and twenty equates to complete anal incontinence.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Rectosigmoid or rectal cancer Exclusion Criteria: * Inoperable
References
Publications (0)
Data not yet available
No reference posted for this study.